sulisobenzone has been researched along with Adverse Drug Event in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosoi, K; Iwase, Y; Kato, M; Kawakami, S; Kojima, H; Matsumoto, Y; Matsuoka, N; Nakamura, K; Ohno, Y; Onoue, S; Osaki, N; Seto, Y; Takagi, H; Toda, T; Wakuri, S; Yamada, S; Yamamoto, T | 1 |
| Fujikawa, M; Igarashi, N; Kawamura, K; Onoue, S; Seto, Y; Tsuda, Y; Yamada, H; Yamada, S; Zhou, Y | 1 |
2 other study(ies) available for sulisobenzone and Adverse Drug Event
| Article | Year |
|---|---|
Establishment and intra-/inter-laboratory validation of a standard protocol of reactive oxygen species assay for chemical photosafety evaluation.
Topics: Benzophenones; Dermatitis, Phototoxic; Drug-Related Side Effects and Adverse Reactions; Humans; Laboratories; Pharmaceutical Preparations; Photochemical Processes; Quinine; Reactive Oxygen Species; Reference Standards; Reproducibility of Results; Ultraviolet Rays; Validation Studies as Topic | 2013 |
Reactive oxygen species assay-based risk assessment of drug-induced phototoxicity: classification criteria and application to drug candidates.
Topics: Animals; BALB 3T3 Cells; Benzophenones; Biological Assay; Chlorpromazine; Dermatitis, Phototoxic; Dihydropyridines; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Guidelines as Topic; Mice; Molecular Structure; Photochemistry; Photosensitivity Disorders; Reactive Oxygen Species; Risk Assessment; Ultraviolet Rays | 2008 |